Reaction

Alpha Haemolytic Streptococcal Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 918 reports · 53 co-occurring drugs

As of the last recalculation, Alpha Haemolytic Streptococcal Infection appears in 918 FAERS reports alongside 53 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 73.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Thiotepa	30	73.6	73.8
Cytarabine	132	58.0	58.1
Fludarabine Phosphate	80	50.4	50.5
Posaconazole Delayed-Release	21	44.3	44.4
Polyethylene Glycol	19	40.6	40.7
Busulfan	25	37.0	37.1
Pegaspargase	19	35.9	36.0
Atovaquone	12	34.2	34.3
Heparin Sodium	20	33.7	33.7
Filgrastim	52	33.2	33.2
Posaconazole	22	31.4	31.5
Vincristine Sulfate	38	30.6	30.7
Dalteparin Sodium	12	26.0	26.1
Valganciclovir Hydrochloride Powder,	13	24.5	24.5
Prochlorperazine	27	22.7	22.7
Anti-Thymocyte Globulin (Rabbit)	8	22.7	22.7
Etoposide	67	22.2	22.2
Valacyclovir	39	22.1	22.1
Micafungin Sodium	8	21.6	21.6
Cyclophosphamide Injection, Solution	142	21.3	21.3
Cyclophosphamide	142	21.3	21.3
Cyclophosphamide For Injection	142	21.3	21.3
Valganciclovir	17	20.8	20.8
Valganciclovir Hydrochloride	17	20.8	20.8
Brentuximab Vedotin	9	20.1	20.1
Hydroxyurea	18	19.7	19.7
Ampicillin	7	19.3	19.3
Ampicillin Sodium	7	19.3	19.3
Azacitidine For	15	19.0	19.0
Cholestyramine	10	18.9	19.0
Mesna Injection	6	16.6	16.6
Mesna	6	16.3	16.3
Cefepime	10	16.0	16.0
Piperacillin Sodium,Tazobactam Sodium	18	15.7	15.7
Anakinra	11	15.2	15.2
Valacyclovir Hydrochloride	43	14.5	14.5
Cefepime Hydrochloride	10	14.2	14.2
Vancomycin	34	13.8	13.8
Melphalan Hydrochloride	15	13.8	13.8
Alteplase	9	13.7	13.7
Sevoflurane	5	13.7	13.7
Azacitidine	17	13.2	13.2
Doxorubicin	47	12.6	12.6
Doxorubicin Hydrochloride	17	12.0	12.0
Norepinephrine	5	10.7	10.7
Ifosfamide	9	9.6	9.6
Blinatumomab	4	8.7	8.7
Dasatinib	14	8.7	8.7
Venetoclax	22	8.3	8.3
Daptomycin	3	7.4	7.4
Crizotinib	4	7.2	7.2
Axicabtagene Ciloleucel	3	6.9	6.9
Aflibercept	9	6.6	6.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.